Moleculin Biotech, Inc. (NASDAQ: MBRX) is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of highly resistant tumors and viruses. The Company’s lead program, Annamycin is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity. Annamycin is currently in development for the treatment of soft tissue sarcoma (STS) lung metastases and relapsed or refractory acute myeloid leukemia (AML).
Moleculin is also engaged in the development of a portfolio of antimetabolites, including WP1122 for the potential treatment of COVID-19 and other viruses, as well as cancer indications including brain tumors, pancreatic and other cancers. Additionally, the Company is developing WP1066, an Immune/Transcription Modulator capable of inhibiting p-STAT3 and other oncogenic transcription factors while also stimulating a natural immune response, targeting brain tumors, pancreatic and other cancers, and WP1220, an analog to WP1066, for the topical treatment of cutaneous T-cell lymphoma.
Company Details
- Employees
- 22
- Founded
- -
- Address
- 5300 Memorial Dr,
- Phone
- 713) 300-5160
- in****@****lin.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- moleculin.com
- HQ
- Houston, Texas
Moleculin Biotech, Inc. Questions
Moleculin Biotech, Inc.'s helpline number is 713) 300-5160
Moleculin Biotech, Inc.'s website is moleculin.com
Moleculin Biotech, Inc.'s LinkedIn profile is https://www.linkedin.com/company/moleculin-llc
Moleculin Biotech, Inc. has
22 employees.
View email and phone details for 22
employees at Moleculin Biotech, Inc..
Moleculin Biotech, Inc.'s industry is
Pharmaceutical Manufacturing
Moleculin Biotech, Inc.'s top competitors are
Human Longevity, Inc.,
Phathom Pharmaceuticals,
Avance Biosciences, Inc.,
Kymera Therapeutics,
Ingeneron,
Avidity Biosciences, Inc.,
Precisedx,
Pathalys Pharma,
Celltex Therapeutics Corporation,
Vandria Sa.
Moleculin Biotech, Inc.'s support email address is info@moleculin.com
Moleculin Biotech, Inc.'s categories are Pharmaceutical Manufacturing
Moleculin Biotech, Inc.'s founding year is 2006
